Bowen’s Disease Treatment Market Segmented By Topical Chemotherapy, Cryotherapy, Photodynamic Therapy Treatment with Distribution Channel in Hospital Pharmacies, Retail Pharmacies, Drug Stores, Clinics, Online Pharmacies
Industry: Healthcare
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Report Type: Ongoing
Report ID: PMRREP29815
Bowen’s disease is very rare form of the skin cancer, it generally affects the squamous cells. The Bowen’s disease can be characterized by presence of red/pink patches on the skin, it can be flat or raised, the progress of the Bowen’s disease very slow taking months or years to spread in neighboring tissues.
Bowen’s disease is easily treatable and can be cured with early diagnosis. As per CDC, Bowen’s disease leads to skin cancer in 1 in 20-30 people, if left undiagnosed or neglected initially.
Spreading of lesions from can be characteristic of possible skin cancer in Bowen’s disease. The rate of Bowen’s disease turning into skin cancer is less than 10% but it can be higher in immune-compromised people.
Increasing awareness about the possible skin cancer in general population is the prime driver of the Bowen’s disease treatment market. Increasing early diagnosis rate and subsequent treatment seeking rate further expected draw traction for the Bowen’s disease treatment market growth. Availability of effective treatment options across all the regions is expected to fuel the growth of the Bowen’s disease treatment market.
Various regulatory exemptions to the manufacturers for developing drugs for rare disease expected to help in building strong pipeline in the Bowen’s disease treatment market.
Increasing R & D funding by the manufacturers due to possible fast track approval as well as granting orphan drug status to the Bowen’s disease treatment drugs is expected to contribute significantly in the Bowen’s disease treatment market growth during the forecast period.
The Bowen’s disease is more frequently observed in Caucasian population above 60 years of age, ageing population of the western countries with higher Caucasian population further expected to drive the growth of the Bowen’s disease treatment market.
Extended efforts by various manufacturers to build stronger pipeline via investing highly in R & D, collaborations, partnerships further expected to drive the growth of the Bowen’s disease treatment market in near future. Whereas, lower diagnosis rate of Bowen’s disease may hamper the potential growth of the Bowen’s disease treatment market.
Treatment Type |
|
Distribution Channel |
|
Region |
|
To know more about delivery timeline for this report Contact Sales